How many days will it take to get rid of a fever after taking Blinatumomab?

The duration of fever after taking Blinatumomab varies from person to person and usually depends on the patient's condition, the dose of treatment and the body's response. Fever is a common side effect during treatment and is part of the Cytokine Release Syndrome (CRS), a normal physiological response of the immune system to fight leukemia cells.

Typically, fever caused by CRS may appear within the first few days of treatment and may gradually lessen over a few days to a week. This time frame is a rough estimate because every patient responds differently.

The medical team will closely monitor the patient's temperature and symptoms to ensure that fever does not escalate to life-threatening levels. If fever is severe or persistent, your doctor may take steps to relieve discomfort, which may include giving antipyretic medications, withholding belintuzumab, or adjusting the dose of treatment to control symptoms.

It is important to emphasize that fever, although it may cause discomfort, is usually part of the treatment and indicates that the immune system is actively fighting the leukemia cells. During treatment, the medical team will pay close attention to the patient's overall condition to ensure they receive the best possible treatment results. Fever usually lessens as treatment progresses, but patients need to closely follow their doctor's advice throughout treatment to ensure this side effect is managed safely and effectively.

In summary, fever during belintuzumab treatment usually subsides gradually over a few days to a week, but the exact timing depends on the patient's condition and treatment response. It is important to communicate promptly with a medical professional for support and guidance to ensure successful treatment.